Wegener's Granulomatosis | Predictors for Survival

Purpose: To evaluate a patient with Wegener's granulomatosis (WG) based upon the predictors of Kamali et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with Wegener's granulomatosis?

Yes

Age at onset

years

Has the person been treated aggressively?

Yes

Has therapy been adjusted to prevent or minimize relapses?

Yes

Initial severity of the WG

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of favorable findings affecting outcome

Number of unfavorable findings affecting outcome

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Clinical Diagnosis, Including Family History For Genetics
- Modified ELK Score of Reinhold-Keller et al for Describing the Extent of Wegener's Granulomatosis
Imaging Studies
- ELK Classification for Wegener's Granulomatosis
- Criteria for Limited Wegener's Granulomatosis
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Differential Diagnosis And Mimics, Red Flags
- Criteria for Limited Wegener's Granulomatosis

Therapy

Selection
- Criteria for a Major Exacerbation of Wegener's Granulomatosis

Monitoring

Response To Therapy
- Wegener's Granulomatosis | Modified Birmingham Vasculitis Activity Score (BVAS)
- ELK Classification for Wegener's Granulomatosis
Disease Progression
- Disease Activity Index for Wegener's Granulomatosis
Comorbid Conditions
- PR3-ANCA Associated Vasculitis | Prognostic Factors with Renal Involvement

Specialty

Immunology/Rheumatology

Objective

severity
prognosis
stage
response to therapy

ICD-10

M31.3 - Wegener's granulomatosis

Info

Purpose: To evaluate a patient with Wegener's granulomatosis (WG) based upon the predictors of Kamali et al.

Specialty: Immunology/Rheumatology

Objective: severity, prognosis, stage, response to therapy

ICD-10: M31.3,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path